Exparel Use in Adductor Canal Block After Total Knee Arthroplasty

Summary

Exparel has been shown to have better pain control compared to previously used infiltration agents, including bupivacaine, while having a minor side effect profile. The purpose of this study is to explore the effectiveness of Exparel (liposomal bupivacaine) in Adductor Canal Blocks for peri-operative pain control following a total knee arthroplasty (TKA) procedure.

Timeline

Start

2020-06-01

Primary completion

2021-09-15

Completion

2021-10-15

Drugs

Indications